Rockefeller Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,102
Closed -$620K 4756
2025
Q4
$620K Buy
6,102
+55
+0.9% +$4.42K ﹤0.01% 1787
2025
Q3
$331K Buy
+6,047
New +$302K ﹤0.01% 1968
2024
Q3
Sell
-57,726
Closed -$2.44M 1631
2024
Q2
$2.44M Buy
57,726
+35,055
+155% +$1.93M 0.01% 902
2024
Q1
$1.57M Buy
22,671
+412
+2% +$26.1K ﹤0.01% 1112
2023
Q4
$1.65M Buy
22,259
+10,613
+91% +$696K 0.01% 981
2023
Q3
$794K Buy
11,646
+2,398
+26% +$203K ﹤0.01% 1164
2023
Q2
$868K Buy
9,248
+5,816
+169% +$454K ﹤0.01% 1145
2023
Q1
$232K Sell
3,432
-67
-2% -$4.31K ﹤0.01% 1735
2022
Q4
$172K Sell
3,499
-1,409
-29% -$57.6K ﹤0.01% 1735
2022
Q3
$158K Sell
4,908
-133
-3% -$5.48K ﹤0.01% 1752
2022
Q2
$197K Sell
5,041
-44
-0.9% -$2.35K ﹤0.01% 1641
2022
Q1
$355K Buy
5,085
+1,938
+62% +$142K ﹤0.01% 1458
2021
Q4
$244K Sell
3,147
-7,654
-71% -$675K ﹤0.01% 1572
2021
Q3
$1.03M Sell
10,801
-11,495
-52% -$1.21M 0.01% 994
2021
Q2
$2.77M Buy
22,296
+5,671
+34% +$677K 0.02% 630
2021
Q1
$2.19M Buy
16,625
+6,513
+64% +$892K 0.01% 556
2020
Q4
$1.34M Buy
10,112
+8,262
+447% +$999K 0.01% 618
2020
Q3
$188K Sell
1,850
-2,816
-60% -$243K ﹤0.01% 1056
2020
Q2
$406K Buy
4,666
+2,364
+103% +$189K ﹤0.01% 772
2020
Q1
$134K Buy
2,302
+911
+65% +$74K ﹤0.01% 930
2019
Q4
$129K Buy
1,391
+41
+3% +$3.6K ﹤0.01% 891
2019
Q3
$122K Buy
1,350
+555
+70% +$63.2K ﹤0.01% 736
2019
Q2
$94K Buy
795
+23
+3% +$2.32K ﹤0.01% 703
2019
Q1
$67K Buy
772
+72
+10% +$6.13K ﹤0.01% 848
2018
Q4
$44K Buy
+700
New +$48K ﹤0.01% 536

Other funds holding EXAS

Rockefeller Capital Management's EXAS Position: Q1 2026 in Review

Rockefeller Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,102 shares — an estimated $620K sold.

Rockefeller Capital Management first reported a position in EXAS in Q4 2018 and held it in 25 quarters. The position peaked at $2.77M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Rockefeller Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 6,102 Exact Sciences shares in Q1 2026, an estimated $620K.
  • Rockefeller Capital Management first reported a position in Exact Sciences in Q4 2018 and held it in 25 quarters.
  • Rockefeller Capital Management's Exact Sciences position peaked at $2.77M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.